Drotaverine hydrochloride
No-Spa Forte is a spasmolytic medicine that reduces pain (painful spasms) in the abdominal and pelvic cavities, i.e., in the digestive tract (stomach and intestines), bile and urinary tracts, and in women, also in the reproductive tract.
No-Spa Forte contains drotaverine hydrochloride as the active substance.
This substance is used for smooth muscle spasms of both nervous and muscular origin. The spasmolytic effect of drotaverine does not depend on the type of innervation and the location of smooth muscles (digestive tract, urogenital system, circulatory system, and bile ducts).
The medicine is metabolized in the liver and excreted mainly in the urine and to a lesser extent through the digestive tract.
Before starting to take No-Spa Forte, discuss it with your doctor.
Caution should be exercised when taking No-Spa Forte:
Do not take the medicine during childbirth.
Tell your doctor about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Caution should be exercised when taking No-Spa Forte with levodopa (a medicine used for Parkinson's disease) due to reduced anti-Parkinsonian effect and increased tremors and stiffness.
No-Spa Forte can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before taking this medicine.
Drotaverine passes through the placenta.
Do not take the medicine during childbirth.
It is not recommended to take this medicine during breastfeeding.
In therapeutic doses, drotaverine taken orally does not affect the ability to drive vehicles and operate machines.
If dizziness occurs, avoid potentially hazardous activities, such as driving or operating machines.
Each tablet contains 104 mg of lactose monohydrate.
If you have been diagnosed with intolerance to some sugars, consult your doctor before taking the medicine.
Take this medicine always as directed by your doctor. If you are unsure, consult your doctor.
The package contains 24 or 48 tablets.
1 tablet contains 80 mg of drotaverine hydrochloride.
Adults:
The daily dose is 120 to 240 mg in 2 to 3 divided doses.
Use in children:
Clinical trials have not been conducted in children.
If No-Spa Forte needs to be used, 80 mg for children:
If you have taken more than the recommended dose, consult your doctor or pharmacist immediately.
Do not take a double dose to make up for a missed dose.
If you have any further doubts about taking this medicine, consult your doctor, pharmacist, or nurse.
Like all medicines, No-Spa Forte can cause side effects, although not everybody gets them.
Rare(may affect up to 1 in 1000 people):
Frequency not known(cannot be estimated from the available data):
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: + 48 22 49 21 301, fax: + 48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of sight and reach of children.
Do not store above 25°C. Store in the original package.
Do not use this medicine after the expiry date stated on the package.
The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
1 tablet of No-Spa Forte contains 80 mg of drotaverine hydrochloride.
The package contains 24 or 48 tablets of 80 mg each.
For more detailed information, consult the marketing authorization holder or parallel importer.
Opella Healthcare France SAS
82 Avenue Raspail
94250 Gentilly
France
Opella Healthcare Hungary Limited Liability Company
(Opella Healthcare Hungary Ltd.)
Lévai utca 5
2112 Veresegyhaz
Hungary
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Lithuanian, country of export marketing authorization number: LT/1/99/0784/007
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.